Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer

NCT07662252 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
186
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Federico II University